5.7
Reazioni di coniugazione di fase II: panoramica
La coniugazione, un componente chiave delle reazioni di biotrasformazione di fase II, è un processo fondamentale nella disintossicazione dai farmaci.…
La coniugazione comporta il legame covalente di un reagente coniugato a farmaci o ai loro metaboliti in presenza di un enzima transferasi.
Questi reagenti sono tipicamente molecole endogene polari che interagiscono con vari gruppi funzionali.
Le reazioni di coniugazione producono prodotti con proprietà fisico-chimiche e farmacologiche modificate.
Quindi, svolgono un ruolo cruciale nella disintossicazione generando metaboliti inattivi e idrosolubili che possono essere facilmente escreti.
Il processo di coniugazione include una fase iniziale di attivazione del farmaco o del reagente ed è limitato dalla capacità, a seconda della disponibilità del reagente coniugante, della transferasi o della capacità di sintetizzare intermedi.
Di conseguenza, dosi eccessive di farmaci possono portare alla saturazione del metabolismo e alla potenziale tossicità.
La capacità di reazioni di coniugazione varia, con il peso molecolare del coniugato che influenza la sua via di escrezione, con coniugati più grandi tipicamente escreti attraverso la bile e coniugati più piccoli espulsi attraverso l'urina.
View the full transcript and gain access to JoVE Core videos
Q1: What is the main purpose of phase II conjugation reactions in drug metabolism?
Phase II conjugation reactions transform drugs and metabolites into inactive, water-soluble forms that can be readily excreted. By covalently linking polar endogenous molecules like glucuronic acid and sulfate to drugs through transferase enzymes, conjugation enhances polarity and eliminates pharmacological activity, effectively ending drug action and facilitating safe elimination from the body.
Q2: How do conjugating reagents modify drug molecules during phase II reactions?
Conjugating reagents are polar endogenous molecules that interact with specific functional groups on drugs or metabolites. These reagents, such as glucuronic acid, sulfate, and glycine, are transferred to the drug by transferase enzymes, significantly increasing the molecular weight of the conjugate and boosting its water solubility to facilitate excretion.
Q3: Why can excess drug doses lead to toxicity during conjugation metabolism?
Conjugation reactions are capacity-limited, depending on the availability of conjugating reagents, transferase enzymes, or the ability to synthesize intermediates. When drug doses exceed the metabolic capacity, conjugation becomes saturated, preventing adequate detoxification and potentially leading to toxic accumulation of the drug or its metabolites in the body.
Q4: What determines whether a drug conjugate is excreted through urine or bile?
The molecular weight of the conjugate influences its excretion pathway. Larger conjugates are typically excreted via bile, while smaller conjugates are expelled through urine. This size-dependent excretion mechanism ensures efficient elimination of phase II conjugation products from the body through appropriate routes.
Q5: How do phase I reactions prepare molecules for phase II conjugation?
Phase I reactions introduce functional groups on drugs and metabolites through oxidation, reduction, or hydrolysis. These newly created functional groups serve as attachment sites for conjugating reagents during phase II reactions, making conjugation a crucial step in comprehensive drug metabolism that follows phase I biotransformation.
Q6: What makes conjugation reactions highly specific in drug biotransformation?
Conjugation reactions are highly specific because they occur between distinct functional groups on the drug or metabolite and particular conjugating agents. Each transferase enzyme catalyzes conjugation with specific substrates and reagents, ensuring that only appropriate drug molecules undergo conjugation with the correct endogenous molecules.
Q7: How does increased water solubility from conjugation affect drug excretion?
Conjugation dramatically increases the water solubility of drug metabolites by adding polar endogenous molecules, transforming lipophilic compounds into hydrophilic conjugates. This enhanced polarity allows conjugates to dissolve readily in aqueous environments, enabling efficient renal and biliary excretion and preventing drug accumulation in tissues.